Question 1

How do I find a good VICP lawyer?

Accepted Answer

Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. You can submit a free inquiry → to have your case forwarded to attorneys with VICP experience, or research Larkin Hoffman, et al., Ltd.'s case history below.

Question 2

How many VICP cases has Larkin Hoffman, et al., Ltd. filed?

Accepted Answer

Larkin Hoffman, et al., Ltd. has filed 9 petitions in the U.S. Vaccine Injury Compensation Program with publicly-available decisions, between 2016 and 2019.

Question 3

What is Larkin Hoffman, et al., Ltd.'s compensation rate?

Accepted Answer

Larkin Hoffman, et al., Ltd.'s overall compensation rate across 9 VICP cases is 78% (7 compensated).

Question 4

How much has Larkin Hoffman, et al., Ltd. won in VICP cases?

Accepted Answer

Cases filed by Larkin Hoffman, et al., Ltd. have resulted in $2.5M in total compensation awards from the U.S. Vaccine Injury Compensation Program (visible-in-public-decisions only).

Question 5

What kinds of vaccine injury cases does Larkin Hoffman, et al., Ltd. handle?

Accepted Answer

Based on the cases on file, Larkin Hoffman, et al., Ltd.'s practice includes Guillain-Barré Syndrome (GBS), Other / multiple, Transverse myelitis, among other vaccine-related conditions.

Filed	Final judgement	Petitioner	Attorney	Firm	Age at Vaccination	Vaccine	Condition	Outcome	Special Master	Award
2017-11-21	2019-05-15	MARK PFEIFER, as Administrator of the Estate of RONALD VINCENT PFEIFER, deceaseddeath	–	–	–	influenza	Guillain-Barré Syndrome (GBS) and respiratory failure	compensated	–	$465,000
2019-02-04	2019-03-01	R.P.	–	–	6mo	influenza	transverse myelitis	denied	–	–
2016-09-29	2018-09-06	James I. Moran	–	–	–	influenza	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)	compensated	–	$175,000
2014-01-02	2018-05-01	L.R.	–	–	–	DTaP, IPV/OPV, PCV-13, Hep B,	acute-onset Transverse Myelitis (“TM”)	compensated	–	$1,181,999
2017-09-26	2018-02-05	Curtis Bakken	–	–	–	influenza	Guillain-Barré Syndrome (GBS)	compensated	–	$138,000
2016-10-06	2017-10-10	William R. Choiniere	–	–	–	influenza	chronic demyelinating polyneuropathy ("CIDP")	compensated	–	$148,000
2016-10-06	2017-05-10	Noreen Fontana	–	–	–	influenza	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)	compensated	–	$135,000
2013-02-05	2017-04-20	Richard T. Dahl	–	–	–	influenza	Guillain-Barré Syndrome	compensated	–	$273,000
2012-09-25	2016-07-27	A.R.	–	–	3.2y	Hepatitis A	nephrotic syndrome	denied	–	–

Larkin Hoffman, et al., Ltd.

Compensation rate by condition vs program baseline

Frequently asked questions about Larkin Hoffman, et al., Ltd.